HIGH RISK
¿Debo evitar dimethyl imidazolidinone durante el embarazo? | VeriMom
Reviewed by VeriMom Editorial Team · Last reviewed
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
Pregnancy-safe products to use instead
Products built around the safer ingredients above, scored "no known risks" or "low risk".

Unknown
100schmidts here now

Sustain Yourself
100Sustain Yourself Natural Deodorant

Avero
100Avero Solid Deodorant

Bitamin
100Bitamin Natural Deodorant N'orange

Mew mew tweet
100Mew mew tweet Cedar Spruce Baking Soda Free

L'Occitane
100L´Occitane Powder To-mousse Facial Exfoliator

bareMinerals
99Complexion Rescue Tinted Hydrating Gel Cream Broad Spectrum SPF 30

Avril
99Déodorant baume

Salt of the Earth
99Salt of the Earth Unscented Natural Refillable Roll-on Deodorant

Facetheory
99facetheory Summer Body Glow B6 SPF 15
Sources & references
Authoritative references used to score this ingredient.
Alternativas seguras a dimethyl imidazolidinone en el embarazo | VeriMom
Ingredientes — Ingredientes
Ver también
FAQ
- ¿Es dimethyl imidazolidinone seguro durante el embarazo?
- Multiple supplier SDS and registration records list 1,3‑dimethyl‑2‑imidazolidinone (CAS 80‑73‑9, also called dimethylimidazolidinone, DMI) as Reproductive Toxicity Category 2 (H361, “suspected of damaging fertility or the unborn child”), and ECHA’s Registry of CLH intentions shows a CLH proposal has been submitted for this substance. These items support a suspected reproductive hazard (H361 → h=2) though a legally binding harmonised CLH entry does not appear to be published as an adopted harmonised classification yet; mechanistic data are limited, so mechanism is scored as theoretical only. DMI is a low‑molecular‑weight polar solvent with measurable dermal absorption in typical solvent roles, so topical cosmetic exposure is assessed as moderate. (Sources: ECHA substance page; ECHA Registry of CLH intentions; supplier SDS/C&L notifications; EWG summary).
- ¿Es dimethyl imidazolidinone seguro durante la lactancia?
- Same hazard basis as pregnancy (listed as Repr. Cat.2 / H361 in registration/SDS material and under active CLH proposal). Mechanism evidence is limited. Dermal/topical exposure could lead to systemic exposure (moderate expected dermal absorption), so breastfeeding exposure is scored as moderate (e=2) because systemic maternal exposure could lead to transfer into milk if maternal systemic levels occur.
- ¿Es dimethyl imidazolidinone seguro para la piel del bebé?
- Hazard and mechanism scores follow the same evidence (H361 / Repr. Cat.2 reporting and CLH proposal). Because DMI has measurable dermal absorption as a small polar solvent, infant skin (0–3 yr) receives a higher exposure score (+1 per guidance) relative to adults, so exposure is scored high. There is no specific infant toxicity data found to alter hazard or mechanism scores.
- ¿Cómo puntúa VeriMom a dimethyl imidazolidinone?
- VeriMom puntúa dimethyl imidazolidinone en 20/100 (riesgo alto) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a dimethyl imidazolidinone en el embarazo?
- Consulta nuestra lista de alternativas seguras a dimethyl imidazolidinone según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.